Las Vegas Clinic

Las Vegas, Nevada 89145

0 studies enrolling now · 11 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, Muscular Dystrophy, Duchenne, Refractory Generalized Myasthenia Gravis

Studies at this site

• Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) — Completed
• Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
• An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy — Stopped early
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy — Completed
• Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy — Completed
• An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy — Stopped early
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy — APPROVED_FOR_MARKETING